---
run_id: halo-evidence-vs-diagnosis-validation-v11-vanilla-02
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: vanilla
run_number: 2
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 201
prompt_source: condition packet (vanilla) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: the frozen Advisor prompt alone, with no added material - see run-packet.md
source_packet_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
condition_packet_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
output_file: model-outputs/vanilla-02.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla (run 02)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `vanilla`, run 2 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 201, on the frozen condition packet.

## Output

**Recommendation: Run the Claim File Review.**

**Why:**
Your current growth is an illusion created by "commercial noise" (bundle pricing and roadmap promises) rather than "product value." You are facing a critical gap between *perceived* utility (Managers using it for training) and *actual* utility (Adjusters abandoning it in production).

The Usage Quality Sprint tracks *if* they use it, but not *why* they stop. The Commercial Cleanroom tests *willingness to pay*, but doesn't tell you how to fix the product. Only the Claim File Review exposes the "truth of the file"—specifically why adjusters in regulated segments cannot explain the logic to reviewers. Because your board locks the budget in 12 days, you need a diagnostic that proves whether SignalPath is a scalable product or a sophisticated demo. Scaling now would be investing in a leaky bucket; narrowing to health-liability without knowing why the logic fails is guessing.

**The strongest reason against it:**
It is a slow, manual, and qualitative process. Unlike the Usage Quality Sprint (which provides dashboards) or the Cleanroom (which provides revenue data), the File Review produces a small sample size that Sales and the Board may dismiss as "anecdotal" or "non-representative" of the broader 16% expansion growth.

**Observable evidence that would change my mind:**
If the "wrong recommendation" tickets in the training channel are revealed to be purely pedagogical (e.g., users don't know which button to click) rather than logical (e.g., the AI suggested an illegal action in a health-liability claim), I would switch to the **Usage Quality Sprint**. If the friction is purely an enablement hurdle, tracking return rates and cleaning up training is the fastest path to stability. However, current evidence suggests a deeper "explainability" crisis that no amount of training can fix.
